ENT Devices are used to diagnose and treat disorders related to ear, nose and throat. A Speech Aid is a device which helps in restoring the verbal communication ability of an individual with mild to severe speech impairment. GlobalData uses proprietary data and analytics to provide a comprehensive report on the speech aid devices devices market, including market shares of different players within Poland. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the speech aid devices market in Poland was Atos Medical followed by InHealth Technologies, Servona and Hood Laboratories.
Voice Prosthesis and Electrolarynx have been tracked under Speech Aid Devices. A Voice Prosthesis is an artificial device usually made up of medical grade silicone that is placed in an opening on the wall that separates the trachea and esophagus called Tracheoesophageal Puncture that enables a laryngectomized person to speak. An Electrolarynx is a battery operated external electromechanical device that is placed against the neck enabling a laryngectomized person to speak.
The value of the speech aid devices devices market within Poland was expected to be over $0.2m in 2023.
For the latest complete market share analysis of speech aid devices device market in Poland, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
